tetano
Editor, Senior Moderator
Anal Chim Acta
. 2022 May 1;1205:339718.
doi: 10.1016/j.aca.2022.339718. Epub 2022 Mar 23.
SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex
Viviana Vásquez[SUP] 1 [/SUP], Maria-Cristina Navas[SUP] 2 [/SUP], Javier A Jaimes[SUP] 3 [/SUP], Jahir Orozco[SUP] 4 [/SUP]
Affiliations
Abstract
Rapid, straightforward, and massive diagnosis of coronavirus disease 2019 (COVID-19) is one of the more important measures to mitigate the current pandemics. This work reports on an immunosensor to rapidly detect the spike protein from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The immunosensing device entraps the spike protein linked to angiotensin-converting enzyme host receptor (ACE2) protein in a sandwich between carboxylated magnetic beads functionalized with an anti-spike antibody and an anti-ACE2 antibody, further labeled with streptavidin (poly)horseradish peroxidase (HRP) reporter enzyme. The particles were confined at the surface of screen-printed gold electrodes, whose signal resulting from the interaction of the enzyme with a mediator was recorded in a portable potentiostat. The immunosensor showed a sensitivity of 0.83 μA∗mL/μg and a limit of detection of 22.5 ng/mL of spike protein, with high reproducibility. As a proof-of-concept, it detected commercial spike protein-supplemented buffer solutions, pseudovirions, isolated viral particles and ten nasopharyngeal swab samples from infected patients compared to samples from three healthy individuals paving the way to detect the virus closer to the patient.
Keywords: ACE2; Coronavirus; Immunosensor; Magnetic beads; SARS-CoV-2; Spike protein.
. 2022 May 1;1205:339718.
doi: 10.1016/j.aca.2022.339718. Epub 2022 Mar 23.
SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex
Viviana Vásquez[SUP] 1 [/SUP], Maria-Cristina Navas[SUP] 2 [/SUP], Javier A Jaimes[SUP] 3 [/SUP], Jahir Orozco[SUP] 4 [/SUP]
Affiliations
- PMID: 35414393
- DOI: 10.1016/j.aca.2022.339718
Abstract
Rapid, straightforward, and massive diagnosis of coronavirus disease 2019 (COVID-19) is one of the more important measures to mitigate the current pandemics. This work reports on an immunosensor to rapidly detect the spike protein from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The immunosensing device entraps the spike protein linked to angiotensin-converting enzyme host receptor (ACE2) protein in a sandwich between carboxylated magnetic beads functionalized with an anti-spike antibody and an anti-ACE2 antibody, further labeled with streptavidin (poly)horseradish peroxidase (HRP) reporter enzyme. The particles were confined at the surface of screen-printed gold electrodes, whose signal resulting from the interaction of the enzyme with a mediator was recorded in a portable potentiostat. The immunosensor showed a sensitivity of 0.83 μA∗mL/μg and a limit of detection of 22.5 ng/mL of spike protein, with high reproducibility. As a proof-of-concept, it detected commercial spike protein-supplemented buffer solutions, pseudovirions, isolated viral particles and ten nasopharyngeal swab samples from infected patients compared to samples from three healthy individuals paving the way to detect the virus closer to the patient.
Keywords: ACE2; Coronavirus; Immunosensor; Magnetic beads; SARS-CoV-2; Spike protein.